Von Hippel-Lindau tumor suppressor protein transforms human neuroblastoma cells into functional neuron-like cells.
暂无分享,去创建一个
Y. Nagashima | M. Yao | M. Baba | S. Kawamoto | K. Okuda | I. Yamamoto | H. Kanno | Hidetoshi Murata | Nobuyoshi Tajima | Masayuki Goto
[1] C. Reynolds,et al. Retinoid therapy of childhood cancer. , 2001, Hematology/oncology clinics of North America.
[2] L. Larsson,et al. Interferon‐γ cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells , 2001, International journal of cancer.
[3] John S. Beech,et al. Resolution of Stroke Deficits Following Contralateral Grafts of Conditionally Immortal Neuroepithelial Stem Cells , 2001, Stroke.
[4] D. Mukhopadhyay,et al. The 104-123 amino acid sequence of the beta-domain of von Hippel-Lindau gene product is sufficient to inhibit renal tumor growth and invasion. , 2001, Cancer research.
[5] Stephen Lee,et al. Role of Exon 2-encoded β-Domain of the von Hippel-Lindau Tumor Suppressor Protein* , 2001, The Journal of Biological Chemistry.
[6] B. Urban,et al. Stereospecific interaction of ketamine with nicotinic acetylcholine receptors in human sympathetic ganglion-like SH-SY5Y cells. , 2000, Anesthesiology.
[7] T. Shuin,et al. Role of the von Hippel-Lindau tumor suppressor protein during neuronal differentiation. , 2000, Cancer research.
[8] R. Klausner,et al. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] L. Pardo,et al. Oncogenic potential of EAG K+ channels , 1999, The EMBO journal.
[10] M. Gstaiger,et al. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. , 1999, Genes & development.
[11] S. Soker,et al. Neuropilin-1 Mediates Collapsin-1/Semaphorin III Inhibition of Endothelial Cell Motility , 1999, The Journal of cell biology.
[12] B. Zbar,et al. Expression of von Hippel–Lindau Protein in Normal and Pathological Human Tissues , 1999, The Histochemical Journal.
[13] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[14] J. Meldolesi,et al. Neurosecretion Competence, an Independently Regulated Trait of the Neurosecretory Cell Phenotype* , 1998, The Journal of Biological Chemistry.
[15] L. Pardo,et al. Cell Cycle–related Changes in the Conducting Properties of r-eag K+ Channels , 1998, The Journal of cell biology.
[16] W. Kaelin,et al. von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids. , 1998, Cancer research.
[17] R. Burk,et al. A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Lovell-Badge,et al. A role for SOX1 in neural determination. , 1998, Development.
[19] S. Påhlman,et al. Activated Transcription of the Human Neuropeptide Y Gene in Differentiating SH‐SY5Y Neuroblastoma Cells Is Dependent on Transcription Factors AP‐1, AP‐2α, and NGFI , 1998, Journal of neurochemistry.
[20] S. Heinemann,et al. Characterization of an eag‐like potassium channel in human neuroblastoma cells , 1998, The Journal of physiology.
[21] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[22] K. Prasad,et al. Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Klausner,et al. The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Trojanowski,et al. Transplantation of Cryopreserved Human Embryonal Carcinoma-Derived Neurons (NT2N Cells) Promotes Functional Recovery in Ischemic Rats , 1998, Experimental Neurology.
[25] M. Turman,et al. Somatostatin expression in human renal cortex and mesangial cells , 1997, Regulatory Peptides.
[26] J. Kukkonen,et al. Locatization of Voltaae‐sensitive Ca2+ Fluxes and Neuropeptide Y Immunoreactivity to Varicosities in SH‐SY5Y Human Neuroblastoma Cells Differentiated by Treatment with the Protein Kinase Inhibitor Staurosporine , 1997, The European journal of neuroscience.
[27] V. Taglietti,et al. Functional changes in sodium conductances in the human neuroblastoma cell line SH-SY5Y during in vitro differentiation. , 1996, Journal of neurophysiology.
[28] Y. Miyagi,et al. VON HIPPEL–LINDAU TUMOUR SUPPRESSOR GENE. LOCALIZATION OF EXPRESSION BY IN SITU HYBRIDIZATION , 1996, The Journal of pathology.
[29] W. Kaelin,et al. Expression pattern of the von Hippel-Lindau protein in human tissues. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[30] A. Kibel,et al. Tumour suppression by the human von Hippel-Lindau gene product , 1995, Nature Medicine.
[31] R. Klausner,et al. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[32] H. Weintraub,et al. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. , 1995, Science.
[33] B. Seizinger,et al. Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene. , 1995, Cancer research.
[34] T. Shuin,et al. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. , 1994, Cancer research.
[35] Y Kubota,et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. , 1994, Cancer research.
[36] J. Brooks,et al. Mutations of the VHL tumour suppressor gene in renal carcinoma , 1994, Nature Genetics.
[37] T. Gotow,et al. Phosphorylation of neurofilament H subunit as related to arrangement of neurofilaments , 1994, Journal of neuroscience research.
[38] J. Gnarra,et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.
[39] C. Markham,et al. Transplantation of Human Neuroblastoma Cells, Catecholaminergic and Non-Catecholaminergic: Effects on Rotational Behavoir in Parkinson's Rat Model , 1992, Journal of neural transplantation & plasticity.
[40] K. Åkerman,et al. Staurosporine induces a neuronal phenotype in SH‐SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12‐O‐tetradecanoyl phorbol‐13 acetate TPA) , 1992, FEBS letters.
[41] David J. Anderson,et al. Two rat homologues of Drosophila achaete-scute specifically expressed in neuronal precursors , 1990, Nature.
[42] M. Shani,et al. The nucleotide sequence of the rat cytoplasmic β–actin gene , 1983 .
[43] G. Shaw,et al. Differential expression of neurofilament triplet proteins in brain development , 1982, Nature.
[44] B. Hallberg,et al. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[45] J. Trojanowski,et al. Neurobiology of human neurons (NT2N) grafted into mouse spinal cord: implications for improving therapy of spinal cord injury. , 2000, Progress in brain research.
[46] V. Taglietti,et al. Functional changes in potassium conductances of the human neuroblastoma cell line SH-SY5Y during in vitro differentiation. , 1998, Journal of neurophysiology.
[47] M. Shani,et al. The nucleotide sequence of the rat cytoplasmic beta-actin gene. , 1983, Nucleic acids research.